Altimmune Inc (ALT)
8.865
+1.04
(+13.36%)
USD |
NASDAQ |
May 15, 16:00
8.71
-0.16
(-1.75%)
After-Hours: 16:06
Altimmune Price: 8.865 for May 15, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 14, 2024 | 7.53 | 8.01 | 7.45 | 7.82 | 3.317M |
| May 13, 2024 | 7.32 | 7.57 | 7.115 | 7.37 | 2.199M |
| May 10, 2024 | 7.65 | 7.81 | 7.06 | 7.22 | 3.049M |
| May 09, 2024 | 7.22 | 8.075 | 7.17 | 7.72 | 4.552M |
| May 08, 2024 | 7.04 | 7.55 | 6.81 | 7.16 | 4.504M |
| May 07, 2024 | 7.40 | 7.40 | 7.045 | 7.27 | 1.705M |
| May 06, 2024 | 7.38 | 7.51 | 7.25 | 7.36 | 1.595M |
| May 03, 2024 | 7.41 | 7.63 | 7.19 | 7.30 | 2.019M |
| May 02, 2024 | 7.18 | 7.35 | 6.81 | 7.19 | 2.681M |
| May 01, 2024 | 6.64 | 7.39 | 6.55 | 7.07 | 4.119M |
| Apr 30, 2024 | 6.35 | 6.73 | 6.31 | 6.55 | 3.215M |
| Apr 29, 2024 | 6.86 | 6.89 | 6.282 | 6.395 | 4.928M |
| Apr 26, 2024 | 7.18 | 7.42 | 6.90 | 7.26 | 2.251M |
| Apr 25, 2024 | 6.88 | 7.25 | 6.78 | 7.20 | 2.316M |
| Apr 24, 2024 | 7.55 | 7.75 | 6.98 | 7.08 | 2.205M |
| Apr 23, 2024 | 7.47 | 8.23 | 7.47 | 7.57 | 3.132M |
| Apr 22, 2024 | 7.03 | 7.55 | 6.85 | 7.47 | 2.370M |
| Apr 19, 2024 | 6.85 | 7.01 | 6.64 | 6.91 | 3.591M |
| Apr 18, 2024 | 6.97 | 7.26 | 6.85 | 6.89 | 3.216M |
| Apr 17, 2024 | 7.65 | 7.65 | 7.01 | 7.04 | 3.641M |
| Apr 16, 2024 | 7.42 | 7.65 | 7.23 | 7.52 | 2.724M |
| Apr 15, 2024 | 7.95 | 7.98 | 7.32 | 7.55 | 3.527M |
| Apr 12, 2024 | 8.33 | 8.33 | 7.75 | 7.99 | 3.046M |
| Apr 11, 2024 | 8.07 | 8.54 | 7.958 | 8.40 | 2.832M |
| Apr 10, 2024 | 8.05 | 8.35 | 7.96 | 8.01 | 2.894M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.53
Minimum
Nov 19 2019
33.26
Maximum
Jul 20 2020
8.724
Average
8.868
Median
Price Benchmarks
| Eli Lilly and Co | 787.60 |
| Amgen Inc | 319.09 |
| Pfizer Inc | 28.82 |
| Viking Therapeutics Inc | 78.02 |
| GlycoMimetics Inc | 0.2774 |
Price Related Metrics
| PS Ratio | 1107.87 |
| Price to Book Value | 3.238 |
| Earnings Yield | -18.84% |
| Market Cap | 628.49M |